首页 > 最新文献

Open Journal of Internal Medicine最新文献

英文 中文
VIONE: Medication Optimization Methodology for Planned Cessation of Non-Essential Medications in Veterans Affairs Medical Centers 退伍军人事务医疗中心计划停止非基本药物的药物优化方法
Pub Date : 2022-12-30 DOI: 10.17140/imoj-6-119
Saraswathy Battar
Many patients take too many medications, many of which were prescribed long ago, without attempts to decrease or stop them, or exploring benefits versus harm for continuing.
许多患者服用了太多的药物,其中许多药物是很久以前开的,没有尝试减少或停止服用,也没有探索继续服用的利弊。
{"title":"VIONE: Medication Optimization Methodology for Planned Cessation of Non-Essential Medications in Veterans Affairs Medical Centers","authors":"Saraswathy Battar","doi":"10.17140/imoj-6-119","DOIUrl":"https://doi.org/10.17140/imoj-6-119","url":null,"abstract":"Many patients take too many medications, many of which were prescribed long ago, without attempts to decrease or stop them, or exploring benefits versus harm for continuing.","PeriodicalId":19579,"journal":{"name":"Open Journal of Internal Medicine","volume":"46 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83077704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Retroperitoneal Hematoma in an Anticoagulated Patient 抗凝患者腹膜后血肿
Pub Date : 2022-12-30 DOI: 10.17140/imoj-6-120
Rajasekar R, Y. D., R. D., A. B, N. R, Aishwarya V Athani
Aim Spontaneous retroperitoneal haemorrhage (SRH), a potentially fatal complication with an atypical presentation, is caused by anticoagulants. The present body of literature does not offer much guidance for diagnosing and treating these situations. This case report’s major goal is to give a general review of the condition’s clinical presentation and anticoagulant therapy in relation to spontaneous retroperitoneal haemorrhage. Case report In this case report, we have covered an instance of retroperitoneal bleeding brought on by anticoagulants. Due to abdominal pain, a computed tomography (CT) scan of the abdomen was performed on the patient, who was using an anticoagulant, and it diagnosed a retroperitoneal hematoma. Conclusion Spontaneous retroperitoneal bleeding is an uncommon occurrence. When patients taking anticoagulant medications appear with stomach pain and distension, retroperitoneal haemorrhage should always be considered a possibility. With this presentation, this is one such instance. An early diagnosis will aid in the proper treatment of the patient.
目的自发性腹膜后出血(SRH)是一种具有不典型表现的潜在致命并发症,是由抗凝剂引起的。目前的文献并没有为诊断和治疗这些情况提供太多的指导。本病例报告的主要目的是对自发性腹膜后出血的临床表现和抗凝治疗进行综述。病例报告在本病例报告中,我们报道了一例由抗凝剂引起的腹膜后出血。由于腹痛,对使用抗凝剂的患者进行了腹部计算机断层扫描(CT),诊断为腹膜后血肿。结论自发性腹膜后出血并不常见。当服用抗凝药物的患者出现胃痛和腹胀时,应始终考虑腹膜后出血的可能性。这次演讲就是这样一个例子。早期诊断有助于对病人进行适当的治疗。
{"title":"A Retroperitoneal Hematoma in an Anticoagulated Patient","authors":"Rajasekar R, Y. D., R. D., A. B, N. R, Aishwarya V Athani","doi":"10.17140/imoj-6-120","DOIUrl":"https://doi.org/10.17140/imoj-6-120","url":null,"abstract":"Aim Spontaneous retroperitoneal haemorrhage (SRH), a potentially fatal complication with an atypical presentation, is caused by anticoagulants. The present body of literature does not offer much guidance for diagnosing and treating these situations. This case report’s major goal is to give a general review of the condition’s clinical presentation and anticoagulant therapy in relation to spontaneous retroperitoneal haemorrhage. Case report In this case report, we have covered an instance of retroperitoneal bleeding brought on by anticoagulants. Due to abdominal pain, a computed tomography (CT) scan of the abdomen was performed on the patient, who was using an anticoagulant, and it diagnosed a retroperitoneal hematoma. Conclusion Spontaneous retroperitoneal bleeding is an uncommon occurrence. When patients taking anticoagulant medications appear with stomach pain and distension, retroperitoneal haemorrhage should always be considered a possibility. With this presentation, this is one such instance. An early diagnosis will aid in the proper treatment of the patient.","PeriodicalId":19579,"journal":{"name":"Open Journal of Internal Medicine","volume":"106 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88041685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determinants of Gestational Diabetes Pedigree Function for Pima Indian Females 皮马印第安女性妊娠糖尿病谱系功能的决定因素
Pub Date : 2022-12-30 DOI: 10.17140/imoj-6-121
Mahashweta Das, Gaurab Bhattacharyya, Rui Gong, Rahul Misra, S. K. Medda, S. Banik, R. Das
{"title":"Determinants of Gestational Diabetes Pedigree Function for Pima Indian Females","authors":"Mahashweta Das, Gaurab Bhattacharyya, Rui Gong, Rahul Misra, S. K. Medda, S. Banik, R. Das","doi":"10.17140/imoj-6-121","DOIUrl":"https://doi.org/10.17140/imoj-6-121","url":null,"abstract":"","PeriodicalId":19579,"journal":{"name":"Open Journal of Internal Medicine","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74298485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
VIONE: An Innovative Electronic Health Record Medication Optimization Methodology 一种创新的电子健康记录药物优化方法
Pub Date : 2022-12-30 DOI: 10.17140/imoj-6-118
Saraswathy Battar
VIONE methodology is an award winning, USA based patient safety project that transformed our national landscape with High Reliability Organization (HRO) concepts. VIONE’s clinical, academic, research, leadership, modern technology tools achieve sustainable reductions and optimization of Potentially Inappropriate Medications (PIM) and adverse outcomes such as hospitalizations, falls, death, clinical waste, etc.
VIONE方法是一项屡获殊荣的美国患者安全项目,通过高可靠性组织(HRO)概念改变了我们的国家景观。VIONE的临床、学术、研究、领导和现代技术工具实现了潜在不适当药物(PIM)和不良后果(如住院、跌倒、死亡、临床浪费等)的可持续减少和优化。
{"title":"VIONE: An Innovative Electronic Health Record Medication Optimization Methodology","authors":"Saraswathy Battar","doi":"10.17140/imoj-6-118","DOIUrl":"https://doi.org/10.17140/imoj-6-118","url":null,"abstract":"VIONE methodology is an award winning, USA based patient safety project that transformed our national landscape with High Reliability Organization (HRO) concepts. VIONE’s clinical, academic, research, leadership, modern technology tools achieve sustainable reductions and optimization of Potentially Inappropriate Medications (PIM) and adverse outcomes such as hospitalizations, falls, death, clinical waste, etc.","PeriodicalId":19579,"journal":{"name":"Open Journal of Internal Medicine","volume":"79 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87082240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Explanatory Factors of Gestational Diabetes Pedigree Function of Pima Indian Heritage Women 皮马印第安血统妇女妊娠糖尿病谱系功能的解释因素
Pub Date : 2022-12-30 DOI: 10.17140/imoj-6-e002
Mahashweta Das, R. Das
Diabetes pedigree function (DPF) predicts diabetes risk based on age and family history, regardless of whether the person is diabetic or not.
糖尿病谱系功能(DPF)预测糖尿病的风险基于年龄和家族史,无论该人是否患有糖尿病。
{"title":"Explanatory Factors of Gestational Diabetes Pedigree Function of Pima Indian Heritage Women","authors":"Mahashweta Das, R. Das","doi":"10.17140/imoj-6-e002","DOIUrl":"https://doi.org/10.17140/imoj-6-e002","url":null,"abstract":"Diabetes pedigree function (DPF) predicts diabetes risk based on age and family history, regardless of whether the person is diabetic or not.","PeriodicalId":19579,"journal":{"name":"Open Journal of Internal Medicine","volume":"92 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83771741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Juvenile Gangrenous Vasculitis of the Scrotum 幼年阴囊坏疽性血管炎
Pub Date : 2021-12-31 DOI: 10.17140/imoj-5-116
C. Nichols, Fnu Nutan
{"title":"Juvenile Gangrenous Vasculitis of the Scrotum","authors":"C. Nichols, Fnu Nutan","doi":"10.17140/imoj-5-116","DOIUrl":"https://doi.org/10.17140/imoj-5-116","url":null,"abstract":"","PeriodicalId":19579,"journal":{"name":"Open Journal of Internal Medicine","volume":"93 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91134132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronavirus Disease-2019 Vaccines and the Vaccination Challenges in India: A Review 2019冠状病毒病疫苗和印度疫苗接种挑战:综述
Pub Date : 2021-12-31 DOI: 10.17140/imoj-5-117
I. R. Rangraze, S. Khan, Yakub Sayyad
The severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) designated as novel coronavirus is a cause of highly infectious disease referred to as coronavirus disease-2019 (COVID-19). The global pandemic that affected millions of people worldwide has claimed many lives and brought about catastrophe in low-income countries. The high mortality and rapid spread of the infection have brought about an urgent need for a safe and effective vaccine to control the pandemic. In this perspective, it becomes essential to understand the structure, mode of transmission, and virulence of SARS-Cov-2. In this article, an emphasis is made on understanding the infection pathogenesis and the host defense mechanisms against the infection to break the chain of transmission. Furthermore, we have tried to summarize the development and characteristics of different types of COVID-19 vaccines. In addition to this, we have highlighted the challenges of the public health system in the procurement and delivery of the vaccine to the community and especially to the most vulnerable society. It becomes the main priority to find support financially and make the public health system ready to imbibe the importance of vaccination through meticulous strategies so that vaccine reaches out to the community.
被称为新型冠状病毒的严重急性呼吸综合征冠状病毒-2 (SARS-CoV-2)是被称为冠状病毒病-2019 (COVID-19)的高度传染性疾病的病因。这一影响到全世界数百万人的全球性流行病夺去了许多人的生命,给低收入国家带来了灾难。这种感染的高死亡率和迅速蔓延使人们迫切需要一种安全有效的疫苗来控制这种大流行病。从这个角度来看,了解SARS-Cov-2的结构、传播方式和毒力变得至关重要。本文将重点了解感染的发病机制和宿主对感染的防御机制,以打破传播链。此外,我们试图总结不同类型的COVID-19疫苗的发展和特点。除此之外,我们还强调了公共卫生系统在向社区,特别是最脆弱的社会采购和提供疫苗方面所面临的挑战。寻求财政支持,并通过细致的战略使公共卫生系统准备好接受疫苗接种的重要性,从而使疫苗接触到社区,成为主要优先事项。
{"title":"Coronavirus Disease-2019 Vaccines and the Vaccination Challenges in India: A Review","authors":"I. R. Rangraze, S. Khan, Yakub Sayyad","doi":"10.17140/imoj-5-117","DOIUrl":"https://doi.org/10.17140/imoj-5-117","url":null,"abstract":"The severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) designated as novel coronavirus is a cause of highly infectious disease referred to as coronavirus disease-2019 (COVID-19). The global pandemic that affected millions of people worldwide has claimed many lives and brought about catastrophe in low-income countries. The high mortality and rapid spread of the infection have brought about an urgent need for a safe and effective vaccine to control the pandemic. In this perspective, it becomes essential to understand the structure, mode of transmission, and virulence of SARS-Cov-2. In this article, an emphasis is made on understanding the infection pathogenesis and the host defense mechanisms against the infection to break the chain of transmission. Furthermore, we have tried to summarize the development and characteristics of different types of COVID-19 vaccines. In addition to this, we have highlighted the challenges of the public health system in the procurement and delivery of the vaccine to the community and especially to the most vulnerable society. It becomes the main priority to find support financially and make the public health system ready to imbibe the importance of vaccination through meticulous strategies so that vaccine reaches out to the community.","PeriodicalId":19579,"journal":{"name":"Open Journal of Internal Medicine","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85624198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Liver Injury after Three Doses of Nitrofurantoin 三剂量呋喃妥因后急性肝损伤
Pub Date : 2021-12-31 DOI: 10.17140/imoj-5-115
T. Pujar, J. Lee, Siegfried W. Yu
A 56-year-old lady presented to the hospital with 2-day history of flu like symptoms. These had begun within a few hours after starting Nitrofurantoin for urinary tract infection that was prescribed by her primary care doctor. Blood tests upon admission revealed elevated aminotransferase levels with normal bilirubin levels. The medication was stopped, and other causes of hepatitis were investigated. Nitrofurantoin induced idiosyncratic drug-induced liver injury (IDILI) was confirmed by excluding all other causes. Patient’s symptoms and liver enzymes improved the next day and she was discharged. A follow-up on the laboratory's nine-days later revealed liver enzymes almost back to normal.
一名56岁女子因2天流感样症状就诊。这些都是在她的初级保健医生开了治疗尿路感染的呋喃妥因后的几个小时内开始的。入院时的血液检查显示转氨酶水平升高,胆红素水平正常。停止用药,并调查肝炎的其他原因。排除所有其他原因,证实呋喃妥因所致特异性药物性肝损伤(IDILI)。次日患者症状及肝酶改善,出院。9天后对实验室进行的随访显示,肝酶几乎恢复正常。
{"title":"Acute Liver Injury after Three Doses of Nitrofurantoin","authors":"T. Pujar, J. Lee, Siegfried W. Yu","doi":"10.17140/imoj-5-115","DOIUrl":"https://doi.org/10.17140/imoj-5-115","url":null,"abstract":"A 56-year-old lady presented to the hospital with 2-day history of flu like symptoms. These had begun within a few hours after starting Nitrofurantoin for urinary tract infection that was prescribed by her primary care doctor. Blood tests upon admission revealed elevated aminotransferase levels with normal bilirubin levels. The medication was stopped, and other causes of hepatitis were investigated. Nitrofurantoin induced idiosyncratic drug-induced liver injury (IDILI) was confirmed by excluding all other causes. Patient’s symptoms and liver enzymes improved the next day and she was discharged. A follow-up on the laboratory's nine-days later revealed liver enzymes almost back to normal.","PeriodicalId":19579,"journal":{"name":"Open Journal of Internal Medicine","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76608807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sodium-Glucose Cotransporter-2 Inhibitors and Cardiovascular Disease: Lessons and the Future 钠-葡萄糖共转运蛋白-2抑制剂与心血管疾病:经验教训和未来
Pub Date : 2020-12-31 DOI: 10.17140/imoj-4-113
A. Kinsara, Atif Al Qubbany, Wail Alkashkar
Diabetes mellitus (DM), an epidemic non-communicable disease, is associated with macro- and micro-vascular complications which may result in sudden cardiac death at a young age. Sodium-glucose cotransporter-2 inhibitors (SGLT2-I) emerged as a new therapeutic option for managing DM with cardiovascular complications as well as diabetic patients with multiple risk factors. Three drugs in this class significantly reduced cardiovascular mortality and heart failure events, in both type 2 diabetes mellitus and non-diabetic patients with a reduced ejection fraction, to prevent heart failure-related hospitalisation. Evidence of kidney protection was another major advantage provided in more than one study. We reviewed recent SGLT2-I related literature and discuss the benefits beyond the cardiac system.
糖尿病是一种流行性非传染性疾病,与大血管和微血管并发症有关,这些并发症可能导致年轻时心脏性猝死。钠-葡萄糖共转运蛋白-2抑制剂(SGLT2-I)作为一种新的治疗选择,用于管理糖尿病合并心血管并发症以及具有多种危险因素的糖尿病患者。这类药物中的三种可显著降低2型糖尿病和射血分数降低的非糖尿病患者的心血管死亡率和心力衰竭事件,以预防心力衰竭相关的住院治疗。保护肾脏的证据是一个以上的研究提供的另一个主要优势。我们回顾了最近与SGLT2-I相关的文献,并讨论了心脏系统以外的益处。
{"title":"Sodium-Glucose Cotransporter-2 Inhibitors and Cardiovascular Disease: Lessons and the Future","authors":"A. Kinsara, Atif Al Qubbany, Wail Alkashkar","doi":"10.17140/imoj-4-113","DOIUrl":"https://doi.org/10.17140/imoj-4-113","url":null,"abstract":"Diabetes mellitus (DM), an epidemic non-communicable disease, is associated with macro- and micro-vascular complications which may result in sudden cardiac death at a young age. Sodium-glucose cotransporter-2 inhibitors (SGLT2-I) emerged as a new therapeutic option for managing DM with cardiovascular complications as well as diabetic patients with multiple risk factors. Three drugs in this class significantly reduced cardiovascular mortality and heart failure events, in both type 2 diabetes mellitus and non-diabetic patients with a reduced ejection fraction, to prevent heart failure-related hospitalisation. Evidence of kidney protection was another major advantage provided in more than one study. We reviewed recent SGLT2-I related literature and discuss the benefits beyond the cardiac system.","PeriodicalId":19579,"journal":{"name":"Open Journal of Internal Medicine","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82888417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proteinuria: A Guide to Diagnosis and Assessment 蛋白尿:诊断和评估指南
Pub Date : 2020-12-31 DOI: 10.17140/imoj-4-112
Sasha-Kay D’Aguilar, A. Skandhan
Proteinuria is a common incidental finding that physicians face in the inpatient and outpatient setting. Proteinuria may represent a benign pathology in asymptomatic patients, or it can be a sign of significant renal or systemic disease. The latter is usually associated with persistent proteinuria or other clinical findings such as renal failure. This article will focus on the mechanisms, causes and diagnostic approach of proteinuria. Proteinuria is a common incidental finding that physicians face in the inpatient and outpatient setting. Proteinuria may represent a benign pathology in asymptomatic patients, or it can be a sign of significant renal or systemic disease. The latter is usually associated with persistent proteinuria or other clinical findings such as renal failure. This article will focus on the mechanisms, causes and diagnostic approach of proteinuria.
蛋白尿是一种常见的偶然发现,医生面对住院和门诊设置。蛋白尿在无症状患者中可能是一种良性病理,也可能是重大肾脏或全身性疾病的征兆。后者通常伴有持续性蛋白尿或其他临床表现,如肾衰竭。本文就蛋白尿的发病机制、病因及诊断方法作一综述。蛋白尿是一种常见的偶然发现,医生面对住院和门诊设置。蛋白尿在无症状患者中可能是一种良性病理,也可能是重大肾脏或全身性疾病的征兆。后者通常伴有持续性蛋白尿或其他临床表现,如肾衰竭。本文就蛋白尿的发病机制、病因及诊断方法作一综述。
{"title":"Proteinuria: A Guide to Diagnosis and Assessment","authors":"Sasha-Kay D’Aguilar, A. Skandhan","doi":"10.17140/imoj-4-112","DOIUrl":"https://doi.org/10.17140/imoj-4-112","url":null,"abstract":"Proteinuria is a common incidental finding that physicians face in the inpatient and outpatient setting. Proteinuria may represent a benign pathology in asymptomatic patients, or it can be a sign of significant renal or systemic disease. The latter is usually associated with persistent proteinuria or other clinical findings such as renal failure. This article will focus on the mechanisms, causes and diagnostic approach of proteinuria. Proteinuria is a common incidental finding that physicians face in the inpatient and outpatient setting. Proteinuria may represent a benign pathology in asymptomatic patients, or it can be a sign of significant renal or systemic disease. The latter is usually associated with persistent proteinuria or other clinical findings such as renal failure. This article will focus on the mechanisms, causes and diagnostic approach of proteinuria.","PeriodicalId":19579,"journal":{"name":"Open Journal of Internal Medicine","volume":"102 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91247366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Open Journal of Internal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1